The oncomodulatory role of human cytomegalovirus in colorectal cancer: Implications for clinical trials

Frontiers in Oncology

Volumn 4, Issue NOV, 2014, Pages

  Chen, Hsin Pai ^a,b   Chan, Yu Jiun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Anti cancer immunity; Anti cancer therapy; Colorectal cancer; Human cytomegalovirus; Oncomodulation

Indexed keywords

CIDOFOVIR; CYCLOOXYGENASE 2; FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; VALGANCICLOVIR; VIRUS DNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BETAHERPESVIRINAE; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CELL INVASION; CELL PROLIFERATION; COLON METASTASIS; COLORECTAL CANCER; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HUMAN; HUMAN CYTOMEGALOVIRUS; INTESTINE EPITHELIUM; LYMPHOCYTIC INFILTRATION; NEPHROTOXICITY; NONHUMAN; ONCOMODULATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; TERATOGENICITY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; VIRUS CARCINOGENESIS;

EID: 84928329828     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00314     Document Type: Article

References (74)

1. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst (2004) 96:1420-5. doi:10.1093/jnci/djh275
2. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 3:149-66. doi:10.1007/s12307-010-0038-3
3. Castillo JP, Kowalik TF. Human cytomegalovirus immediate early proteins and cell growth control. Gene (2002) 290:19-34. doi:10.1016/S0378-1119(02)00566-8
4. Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology (1996) 39:259-69.
5. Powers C, DeFilippis V, Malouli D, Früh K. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol (2008) 325:333-59. doi:10.1007/978-3-540-77349-8_19
6. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res (2002) 62:3347-50. doi:10.3892/ijo.21.1.31
7. Giraldo G, Beth E, Huang ES. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 26:23-9. doi:10.1002/ijc.2910260105
8. Huang G, Yan Q, Wang Z, Chen X, Zhang X, Guo Y, et al. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease. Int J Oncol (2002) 21:31-6.
9. Pacsa AS, Kummerlander L, Pejtsik B, Pali K. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst (1975) 55:775-81.
10. Sanford EJ, Geder L, Laychock A, Rohner TJ Jr, Rapp F. Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol (1977) 118:789-92.
11. Huang ES, Roche JK. Cytomegalovirus D.N.A. and adenocarcinoma of the colon: evidence for latent viral infection. Lancet (1978) 1:957-60. doi:10.1016/S0140-6736(78)90248-9
12. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet (2002) 360:1557-63. doi:10.1016/S0140-6736(02)11524-8
13. Chen HP, Jiang JK, Chen CY, Chou TY, Chen YC, Chang YT, et al. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol (2012) 54:240-4. doi:10.1016/j.jcv.2012.04.007
14. Chen HP, Jiang JK, Lai PY, Chen CY, Chou TY, Chen YC, et al. Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17. Clin Microbiol Infect (2014) 20:664-71. doi:10.1111/1469-0691.12412
15. Cinatl J Jr, Vogel JU, Kotchetkov R, Wilhelm Doerr H. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol Rev (2004) 28:59-77. doi:10.1016/j.femsre.2003.07.005
16. Akintola-Ogunremi O, Luo Q, He TC, Wang HL. Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol (2005) 123:244-9. doi:10.1309/9QVRHDJUK6H2TURB
17. Boguszaková L, Hirsch I, Brichácek B, Faltỳn J, Fric P, Dvoráková H, et al. Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol (1988) 32:303-8.
18. Brichacek B, Hirsch I, Zavadova H, Prochazka M, Faltyn J, Vonka V. Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology (1980) 14:223-7. doi:10.1159/000149187
19. Hart H, Neill WA, Norval M. Lack of association of cytomegalovirus with adenocarcinoma of the colon. Gut (1982) 23:21-30. doi:10.1136/gut.23.1.21
20. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol (2012) 86:854-64. doi:10.1128/JVI.06097-11
21. Chen HP, Lin JC, Yang SP, Lan YC, Weng WS, Tsai CH, et al. The type-2 variant of human cytomegalovirus glycoprotein n (gn-2) is not the rarest in the Chinese population of Taiwan: influence of primer design. J Virol Methods (2008) 151:161-4. doi:10.1016/j.jviromet.2008.03.018
22. Koshiba M, Ogawa K, Hamazaki S, Sugiyama T, Ogawa O, Kitajima T. The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. Pathol Res Pract (1993) 189:66-72. doi:10.1016/S0344-0338(11)80118-4
23. Rogers BB, Alpert LC, Hine EA, Buffone GJ. Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol (1990) 136:541-8.
24. Ferrer I, Armstrong J, Capellari S, Parchi P, Arzberger T, Bell J, et al. Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a Brainnet Europe study. Brain Pathol (2007) 17:297-303. doi:10.1111/j.1750-3639.2007.00073.x
25. Rollo F, Ermini L, Luciani S, Marota I, Olivieri C. Studies on the preservation of the intestinal microbiota's DNA in human mummies from cold environments. Med Secoli (2006) 18:725-40.
26. Esclatine A, Bellon A, Michelson S, Servin AL, Quero AM, Geniteau-Legendre M. Differentiation-dependent redistribution of heparan sulfate in epithelial intestinal caco-2 cells leads to basolateral entry of cytomegalovirus. Virology (2001) 289:23-33. doi:10.1006/viro.2001.1122
27. Jarvis MA, Wang CE, Meyers HL, Smith PP, Corless CL, Henderson GJ, et al. Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol (1999) 73:4552-60.
28. McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis (1989) 160:1-10. doi:10.1093/infdis/160.1.1
29. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol (2007) 42:563-70. doi:10.1016/j.exger.2007.01.005
30. Savva GM, Pachnio A, Kaul B, Morgan K, Huppert FA, Brayne C, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell (2013) 12:381-7. doi:10.1111/acel.12059
31. Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G. Role of persistent CMV infection in configuring t cell immunity in the elderly. Immun Ageing (2007) 4:2. doi:10.1186/1742-4933-4-2
32. Hadrup SR, Strindhall J, Køllgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded cd8 t cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific t cells in the very elderly. J Immunol (2006) 176:2645-53. doi:10.4049/jimmunol.176.4.2645
33. Koch S, Solana R, Dela Rosa O, Pawelec G. Human cytomegalovirus infection and t cell immunosenescence: a mini review. Mech Ageing Dev (2006) 127:538-43. doi:10.1016/j.mad.2006.01.011
34. Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C. Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother (2006) 55:981-6. doi:10.1007/s00262-005-0109-3
35. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct m2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer (2006) 42:717-27. doi:10.1016/j.ejca.2006.01.003
36. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A. Tgf-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower tgf-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer (2007) 7:156. doi:10.1186/1471-2407-7-156
37. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an m1 macrophage. J Immunol (2008) 181:698-711. doi:10.4049/jimmunol.181.1.698
38. Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A, et al. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res (2011) 17:4642-9. doi:10.1158/1078-0432.CCR-11-0414
39. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory t cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 353:2654-66. doi:10.1056/NEJMoa051424
40. Chan G, Bivins-Smith ER, Smith MS, Yurochko AD. Transcriptome analysis of nf-kappab- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J Virol (2008) 82:1040-6. doi:10.1128/JVI.00864-07
41. Evans C, Dalgleish AG, Kumar D. Review article: immune suppression and colorectal cancer. Aliment Pharmacol Ther (2006) 24:1163-77. doi:10.1111/j.1365-2036.2006.03075.x
42. Cabrera T, Collado A, Fernandez MA, Ferron A, Sancho J, Ruiz-Cabello F, et al. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens (1998) 52:114-23. doi:10.1111/j.1399-0039.1998.tb02274.x
43. Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, et al. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients. Lab Invest (2002) 82:1725-33. doi:10.1097/01.LAB.0000043124.75633.ED
44. Mocarski ES Jr. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol (2002) 10:332-9. doi:10.1016/S0966-842X(02)02393-4
45. Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, et al. The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis (2000) 181:51-7. doi:10.1086/315184
46. Zhang Y, Wang YL, Liu YW, Li Q, Yuan YH, Niu WY, et al. Change of peripheral blood mononuclear cells IFN-gamma, IL-10, and TGF-beta1 MRNA expression levels with active human cytomegalovirus infection in orthotopic liver transplantation. Transplant Proc (2009) 41:1767-9. doi:10.1016/j.transproceed.2009.03.064
47. Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Strååt K, et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol (2013) 57:36-42. doi:10.1016/j.jcv.2012.12.018
48. Soderberg-Naucler C, Rahbar A, Stragliotto G. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med (2013) 369:985-6. doi:10.1056/NEJMc1302145
49. Brown JR, DuBois RN. Cox-2: a molecular target for colorectal cancer prevention. J Clin Oncol (2005) 23:2840-55. doi:10.1200/JCO.2005.09.051
50. Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev (2004) 23:63-75. doi:10.1023/A:1025863029529
51. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The cox-2/pge2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis (2009) 30:377-86. doi:10.1093/carcin/bgp014
52. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol (2002) 97:1037-41. doi:10.1111/j.1572-0241.2002.05625.x
53. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 325:1593-6. doi:10.1056/NEJM199112053252301
54. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 348:891-9. doi:10.1056/NEJMoa021735
55. Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut (2002) 50:857-60. doi:10.1136/gut.50.6.857
56. Yi HA, Kim MS, Jang SY, Lee YM, Ahn JH, Lee CH. Cellular signals involved in cyclooxygenase-2 expression induced by human cytomegalovirus. Virus Res (2009) 146:89-96. doi:10.1016/j.virusres.2009.09.004
57. Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A. (2002) 99:3932-7. doi:10.1073/pnas.052713799
58. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology (1998) 55:575-81. doi:10.1159/000011915
59. Caposio P, OrloffSL, Streblow DN. The role of cytomegalovirus in angiogenesis. Virus Res (2011) 157:204-11. doi:10.1016/j.virusres.2010.09.011
60. Botto S, Streblow DN, DeFilippis V, White L, Kreklywich CN, Smith PP, et al. IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood (2011) 117:352-61. doi:10.1182/blood-2010-06-291245
61. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, PleskoffO, et al. Human cytomegalovirus-encoded chemokine receptor us28 promotes tumorigenesis. Proc Natl Acad Sci U S A (2006) 103:13068-73. doi:10.1073/pnas.0604433103
62. Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M, et al. Human cytomegalovirus us28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res (2011) 71:6643-53. doi:10.1158/0008-5472.CAN-11-0744
63. Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, et al. Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in trp53± mice. Cancer Res (2012) 72:5669-74. doi:10.1158/0008-5472.CAN-12-2425
64. Goldmacher VS, Bartle LM, Skaletskaya A, Dionne CA, Kedersha NL, Vater CA, et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to bcl-2. Proc Natl Acad Sci U S A (1999) 96:12536-41. doi:10.1073/pnas.96.22.12536
65. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 98:7829-34. doi:10.1073/pnas.141108798
66. Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol (2007) 82:1375-81. doi:10.1189/jlb.0607338
67. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev (2004) 23:101-17. doi:10.1023/A:1025867130437
68. Straat K, de Klark R, Gredmark-Russ S, Eriksson P, Soderberg-Naucler C. Infection with human cytomegalovirus alters the mmp-9/timp-1 balance in human macrophages. J Virol (2009) 83:830-5. doi:10.1128/JVI.01363-08
69. Koskensalo S, Hagström J, Linder N, Lundin M, Sorsa T, Louhimo J, et al. Lack of mmp-9 expression is a marker for poor prognosis in dukes' b colorectal cancer. BMC Clin Pathol (2012) 12:24. doi:10.1186/1472-6890-12-24
70. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY. A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? J Surg Res (2004) 121:214-21. doi:10.1016/j.jss.2004.04.002
71. Botero JE, Contreras A, Parra B. Effects of cytomegalovirus infection on the mRNA expression of collagens and matrix metalloproteinases in gingival fibroblasts. J Periodontal Res (2008) 43:649-57. doi:10.1111/j.1600-0765.2007.01053.x
72. Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes (2004) 11:77-86.
73. Biron KK. Antiviral drugs for cytomegalovirus diseases. Antiviral Res (2006) 71:154-63. doi:10.1016/j.antiviral.2006.05.002
74. Stragliotto G, Rahbar A, Solberg NW, Lilja A, Taher C, Orrego A, et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer (2013) 133:1204-13. doi:10.1002/ijc.28111